The immune-inflamed phenotype of S/R RCC tumors was also evaluated by IF staining for CD8+ T cells in a subset of the CheckMate cohort (N of S/R = 29 and N of non-S/R = 186; Supplementary Fig. S6b, c and Supplementary Data 10). This evidence concerns the gene CD8A and renal cell carcinoma.